Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
TEXT: Mapping Customer Journeys in a Digital World
Summary
In this episode, Tom Caravela is joined by Mitchell D’Rozario to explore the challenges and strategies in engaging with Key Opinion Leaders (KOLs). They discuss the importance of understanding digital communication preferences and establishing value through effective timing and methods. The conversation delves into leveraging publication history and digital tools to enhance MSL access and engagement, while balancing virtual and in-person interactions. They highlight the role of compassionate leadership, navigating social media, and adapting strategies in difficult times. Mitchell shares insights on overcoming obstacles, learning from failures, and provides tips for aspiring MSLs.
Mitchell D’Rozario, Medical Science Liaison at Genentech discusses digital tools and techniques for MSLs to Map Customer Journeys: pain points and opportunities.
Mitch shares…
👉 How to go about developing a TEXT relationship with your Key Opinion Leaders
👉 What key questions you should be asking
👉 How and why the use of social media is so important
👉 Unique ways to engage with KOLs and gain better access
👉 Advice on performance and meeting goals
Key Opinion Leaders, Digital Communication, Medical Science Liaison, Social Media Engagement, Compassionate Leadership
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary